[Pharmaceutical preparation of BRL 25000].
D000284:Administration, Oral; D000658:Amoxicillin / Q000008:administration & dosage / Q000494:pharmacology; D019980:Amoxicillin-Potassium Clavulanate Combination; D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000494:pharmacology; D001419:Bacteria / Q000187:drug effects; D001424:Bacterial Infections / Q000188:drug therapy; D055598:Chemical Phenomena; D002621:Chemistry; D002627:Chemistry, Physical; D002969:Clavulanic Acids / Q000008:administration & dosage / Q000494:pharmacology; D004338:Drug Combinations / Q000008:administration & dosage / Q000494:pharmacology; D004355:Drug Stability; D005260:Female; D006801:Humans; D007928:Lethal Dose 50; D051379:Mice; D010403:Penicillin Resistance; D011247:Pregnancy; D051381:Rats
D000900:Anti-Bacterial Agents; D002969:Clavulanic Acids; D004338:Drug Combinations; D019980:Amoxicillin-Potassium Clavulanate Combination; D000658:Amoxicillin